| (84) |
Designated Contracting States: |
|
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL
NO PL PT RO RS SE SI SK SM TR |
| (43) |
Date of publication of application: |
|
28.08.2013 Bulletin 2013/35 |
| (73) |
Proprietor: Vergell Medical S.A. |
|
1204 Geneva (CH) |
|
| (72) |
Inventors: |
|
- Kratz, Felix
79238 Ehrenkirchen (DE)
- Warnecke, André
79117 Freiburg (DE)
|
| (74) |
Representative: Müller-Boré & Partner
Patentanwälte PartG mbB |
|
Friedenheimer Brücke 21
80639 München
80639 München (DE) |
| (56) |
References cited: :
EP-A1- 1 419 788
|
US-A1- 2004 063 635
|
|
| |
|
|
- DESAI N ET AL: "Antitumor activity, and antiangiogenic activity of nanoparticle albumin-bound
nab-rapamycin in combination with nab-paclitaxel", CANCER RESEARCH, vol. 69, no. 2,
Suppl. 1 January 2009 (2009-01), XP002678704, & 31ST ANNUAL SAN ANTONIO BREAST CANCER
SYMPOSIUM; SAN ANTONIO, TX, USA; DECEMBER 10 -14, 2008 ISSN: 0008-5472 Retrieved from
the Internet: URL:http://cancerres.aacrjournals.org/cgi/ content/meeting_abstract/69/2_MeetingAbstr
acts/3125 [retrieved on 2012-06-26]
- CHARLOTTE FOWLER J ET AL: "Dual-isotope lymphoscintigraphy using albumin nanocolloid
differentially labeled with 111In and 99mTc", ACTA ONCOLOGICA, vol. 46, no. 1, 1 January
2007 (2007-01-01), pages 105-110, XP002631492, INFORMA HEALTHCARE, LONDON, GB ISSN:
0284-186X, DOI: 10.1080/02841860600635854
- FELIX KRATZ: "DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin
to enter clinical trials", EXPERT OPINION ON INVESTIGATIONAL DRUGS, vol. 16, no. 6,
1 June 2007 (2007-06-01), pages 855-866, XP055031139, ISSN: 1354-3784, DOI: 10.1517/13543784.16.6.855
- ANDRÉ WARNECKE ET AL: "Synthesis, Cleavage Profile, and Antitumor Efficacy of an Albumin-Binding
Prodrug of Methotrexate that is Cleaved by Plasmin and Cathepsin B", ARCHIV DER PHARMAZIE,
vol. 340, no. 8, 1 August 2007 (2007-08-01), pages 389-395, XP055031081, ISSN: 0365-6233,
DOI: 10.1002/ardp.200700025
- ELSADEK B ET AL: "Development of a novel prodrug of paclitaxel that is cleaved by
prostate-specific antigen: An in vitro and in vivo evaluation study", EUROPEAN JOURNAL
OF CANCER, vol. 46, no. 18, 1 December 2010 (2010-12-01), pages 3434-3444, XP027546744,
PERGAMON PRESS, OXFORD, GB ISSN: 0959-8049 [retrieved on 2010-12-01]
- BAKHEET ELSADEK ET AL: "Impact of albumin on drug delivery - New applications on the
horizon", JOURNAL OF CONTROLLED RELEASE, vol. 157, no. 1, 1 January 2012 (2012-01-01),
pages 4-28, XP055031206, ISSN: 0168-3659, DOI: 10.1016/j.jconrel.2011.09.069
- Björn Schmid ET AL: "Albumin-Binding Prodrugs of Camptothecin and Doxorubicin with
an Ala-Leu-Ala-Leu-Linker That Are Cleaved by Cathepsin B: Synthesis and Antitumor
Efficacy", Bioconjugate Chemistry, vol. 18, no. 3, 1 May 2007 (2007-05-01), pages
702-716, XP055076344, ISSN: 1043-1802, DOI: 10.1021/bc0602735
- CHUNG D E ET AL: "Development of a novel albumin-binding prodrug that is cleaved by
urokinase-type-plasminogen activator (uPA)", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,
PERGAMON, AMSTERDAM, NL, vol. 16, no. 19, 1 October 2006 (2006-10-01), pages 5157-5163,
XP027966605, ISSN: 0960-894X [retrieved on 2006-10-01]
|
|
